scholarly journals Prognostic factors for renal allograft survival in patients with immunoglobulin A nephropathy: A case control study

2014 ◽  
Vol 9 (4) ◽  
pp. 1179-1184 ◽  
Author(s):  
JUN-QI GUO ◽  
BAO-LIN SONG ◽  
ZHI-XIAN WU ◽  
WEI-ZHEN WU ◽  
LIU-TAO LUO ◽  
...  
Author(s):  
Francesc Moreso ◽  
Angel Alonso ◽  
Miguel A Gentil ◽  
Miguel González-Molina ◽  
Lluis Capdevila ◽  
...  

2006 ◽  
Vol 54 (11) ◽  
pp. 3573-3582 ◽  
Author(s):  
Berit Flatø ◽  
Anna-Maria Hoffmann-Vold ◽  
Andreas Reiff ◽  
ØYstein Førre ◽  
Gunnhild Lien ◽  
...  

2019 ◽  
Vol 29 ◽  
pp. 102-106
Author(s):  
Kevin Afshari ◽  
Abbas Chabok ◽  
Peter Naredi ◽  
Kenneth Smedh ◽  
Maziar Nikberg

2020 ◽  
Vol 114 (5) ◽  
pp. 346-354 ◽  
Author(s):  
Thais Almeida Marques da Silva ◽  
Maria Helena Franco Morais ◽  
Helen Maria de Oliveira Ramos Lopes ◽  
Stefanne Aparecida Gonçalves ◽  
Fernanda do Carmo Magalhães ◽  
...  

Abstract Background The aim of this study was to identify the prognostic factors associated with death from visceral leishmaniasis (VL) considering the clinical evolution of patients through a case-control study. Methods We randomly selected 180 cases (death caused by VL) and 180 controls (cured) from Belo Horizonte's hospitals in Brazil, according to data found in the patients' medical records. Five models of multivariate logistic regression were performed following the chronological order of the variables between the onset of the symptoms and evolution of the VL cases. Results Considering the multivariate models and the stages of clinical evolution of VL, the prognostic factors associated with death are: age >60 y, minor hemorrhagic phenomena, increased abdominal volume, jaundice, dyspnea, malnutrition, TB, billirubin >2 mg/dL, Aspartate Aminotransferase (AST) or Alanine Aminotransferase (ALT) >100 U/L, leukocytes >7000/mm3, hemoglobin <7 g/dL, platelets <50 000/mm3 and infection without defined focus and bleeding. Conclusions Knowledge regarding the prognostic factors associated with death from VL in different stages of the disease in large Brazilian urban centers such as Belo Horizonte may help optimize patient management strategies and contribute to reduce the high fatality rates in these cities.


Lung Cancer ◽  
2008 ◽  
Vol 61 (2) ◽  
pp. 235-243 ◽  
Author(s):  
Oluf Dimitri Roe ◽  
Jenette Creaney ◽  
Steinar Lundgren ◽  
Erik Larsson ◽  
Helmut Sandeck ◽  
...  

Head & Neck ◽  
2010 ◽  
Vol 32 (11) ◽  
pp. 1460-1466 ◽  
Author(s):  
Estela Kaminagakura ◽  
José Guilherme Vartanian ◽  
Sabrina Daniela da Silva ◽  
Carlos Roberto dos Santos ◽  
Luiz Paulo Kowalski

Sign in / Sign up

Export Citation Format

Share Document